Leibniz-Institute for Molecular Pharmacology (FMP), Berlin, Germany.
PLoS One. 2011 Apr 14;6(4):e18662. doi: 10.1371/journal.pone.0018662.
MHC class II molecules (MHC II) play a pivotal role in the cell-surface presentation of antigens for surveillance by T cells. Antigen loading takes place inside the cell in endosomal compartments and loss of the peptide ligand rapidly leads to the formation of a non-receptive state of the MHC molecule. Non-receptiveness hinders the efficient loading of new antigens onto the empty MHC II. However, the mechanisms driving the formation of the peptide inaccessible state are not well understood. Here, a combined approach of experimental site-directed mutagenesis and computational modeling is used to reveal structural features underlying "non-receptiveness." Molecular dynamics simulations of the human MHC II HLA-DR1 suggest a straightening of the α-helix of the β1 domain during the transition from the open to the non-receptive state. The movement is mostly confined to a hinge region conserved in all known MHC molecules. This shift causes a narrowing of the two helices flanking the binding site and results in a closure, which is further stabilized by the formation of a critical hydrogen bond between residues αQ9 and βN82. Mutagenesis experiments confirmed that replacement of either one of the two residues by alanine renders the protein highly susceptible. Notably, loading enhancement was also observed when the mutated MHC II molecules were expressed on the surface of fibroblast cells. Altogether, structural features underlying the non-receptive state of empty HLA-DR1 identified by theoretical means and experiments revealed highly conserved residues critically involved in the receptiveness of MHC II. The atomic details of rearrangements of the peptide-binding groove upon peptide loss provide insight into structure and dynamics of empty MHC II molecules and may foster rational approaches to interfere with non-receptiveness. Manipulation of peptide loading efficiency for improved peptide vaccination strategies could be one of the applications profiting from the structural knowledge provided by this study.
MHC II 类分子(MHC II)在细胞表面呈递抗原以供 T 细胞监测方面发挥着关键作用。抗原加载发生在细胞内的内体隔室中,肽配体的丢失会迅速导致 MHC 分子形成不可接受的状态。不可接受性会阻碍新抗原有效加载到空的 MHC II 上。然而,导致形成肽不可接近状态的机制尚不清楚。在这里,采用实验定点突变和计算建模相结合的方法来揭示“不可接受性”的结构特征。人 MHC II HLA-DR1 的分子动力学模拟表明,在从开放状态到不可接受状态的转变过程中,β1 结构域的α-螺旋会变直。这种运动主要局限于所有已知 MHC 分子都保守的铰链区域。这种转变导致结合位点两侧的两条螺旋变窄,并导致闭合,其中αQ9 和βN82 之间形成关键氢键进一步稳定了这种闭合。突变实验证实,用丙氨酸替换这两个残基中的任一个都会使蛋白质高度敏感。值得注意的是,当突变的 MHC II 分子在成纤维细胞表面表达时,也观察到了负载增强。总之,通过理论方法和实验确定的空 HLA-DR1 不可接受状态的结构特征揭示了高度保守的残基,这些残基在 MHC II 的可接受性中起着关键作用。肽丢失后肽结合槽的重排的原子细节提供了对空 MHC II 分子结构和动力学的深入了解,并可能促进合理的方法来干扰不可接受性。操纵肽加载效率以提高肽疫苗接种策略可能是受益于本研究提供的结构知识的应用之一。